Accessibility: Skip TopNav
TEVA ENROLLS PATIENTS FOR A SECOND LARGE GLOBAL PHASE III TRIAL OF ORAL LAQUINIMOD
July 16, 2008 02:45 ET
| Source:
Active Biotech
Active Biotech
For release content, please refer to the attachment.
Attachments
TEVA ENROLLS PATIENTS FOR A SECOND LARGE GLOBAL PHASE III TRIAL OF ORAL LAQUINIMOD ...